Cancer is a complex and dynamic disease that is difficult to treat due to its heterogeneous nature at multiple scales. Standard therapies such as surgery, radiation, and chemotherapy often fail, therefore superior therapies must be developed. Electroporation-based therapies offer an alternative to standard treatments, utilizing pulsed electric fields to permeabilize cell membranes to either enhance drug delivery (electrochemotherapy) or induce cancer cell death (irreversible electroporation). Electroporation treatments show promise in the clinic, however, are limited in the size of tumors that they can safely treat without increasing the applied voltage to an extent that induces thermal damage or muscle contractions in patients. A method to increase ablation size safely is needed. To make this advancement and to advance other cancer treatments as well, better in vitro tumor models are needed. Heterogeneity not only makes cancer difficult to treat, but also difficult to recapitulate in vitro. This dissertation addresses the complementary need to develop both better cancer therapies and more physiologically relevant in vitro tumor models. My results demonstrate that by using a calcium adjuvant with irreversible electroporation treatment, ablation size can be increased without using a higher applied voltage. Additional mechanistic studies identified signaling pathways that were differentially dysregulated under calcium and no calcium conditions, impacting cell death. Finally, I have successfully encapsulated cells in fibrin microgels which may enable the creation of more physiologically relevant and complex 3D in vitro and ex-vivo platforms to investigate IRE as well as other tumor therapies. / Doctor of Philosophy / Cancer is a complex and dynamic disease. Heterogeneity exists at the single cell, tumor, and patient levels making it difficult to establish a unified target for therapy. Standard therapies such as surgery, radiation, and chemotherapy often fail for this reason, therefore superior therapies must be developed. Electroporation-based therapies offer an alternative to standard treatments, utilizing pulsed electric fields to permeabilize cell membranes to either enhance drug delivery (electrochemotherapy) or induce cancer cell death (irreversible electroporation). Electroporation treatments show promise in the clinic, however, are limited in the size of tumors that they can safely treat without increasing the applied voltage to an extent that induces thermal damage or muscle contractions in patients. A method to increase ablation size safely is needed. To make this advancement and to advance other cancer treatments as well, better tumor models are needed. Many of the same challenges in treating cancer serve as challenges in creating physiologically relevant tumor models. In this dissertation, I have developed a simplified platform to test whether using a calcium additive with irreversible electroporation therapies enhances ablation size. My results demonstrate that by using a calcium additive with irreversible electroporation treatment, ablation size can be increased without using a higher applied voltage. In addition, the biological pathways responsible for cell death in irreversible electroporation treatment with and without calcium were studied. Finally, I have successfully encapsulated cells in fibrin microgels that can be used to create better tumor models that encompass the heterogeneity of tumors found in the body.

This thesis presents analysis, design, implementation, and testing of electrostatically actuated MEMS microvalves. The microvalves are specifically designed for lab-on-a-chip applications to achieve leakage ratios below 0.1 at pressure levels in the order of 101 kPa. For this purpose, two different microvalves are presented in the study. In the proposed designs, electrostatic actuation scheme is utilized to operate the microvalves in normally open and normally closed modes. Characterization of normally open microvalves show that, microvalves with radii ranging between 250

Antimicrobial resistance in bacteria is a global health challenge with a projected fallout of 10 million deaths annually and cumulative costs of over 1 trillion dollars by 2050. The currently available tools exploited in the detection of bacteria or their DNA can be expensive, time inefficient, or lack multiplex capabilities among others. The research work highlighted in this dissertation advances techniques employed in the phenotypic or genotypic detection of bacteria and their DNA. In this dissertation, I present polymethyl methacrylate-pressure sensitive adhesive microfluidic platforms developed using a time-efficient, inexpensive fabrication technique. Microfluidic devices were then equipped with functionalized monoliths and utilized for sequence-specific capture and detection of picomolar concentrations of bacterial plasmid DNA harvested from cultured bacteria. I then showed multiplex detection of multiple bacteria gene targets in these devices with an improved monolith column. Finally, I demonstrated a genotypic approach to studying single bacteria growth in water-in-oil droplets with nanomolar concentrations of a fluorescence reporter, and detection via laser-induced fluorescence after convenient room temperature 2-h incubation conditions. The systems and methods described herein show potential to advance tools needed to address the surging problems and effects of drug-resistant bacteria.

Research on bacteria in their biofilm form is limited by the ability to artificially culture bacterial biofilms in a system that permits the visualization of individual cells. The experiments comprising this thesis research are on-going investigations of bacterial culture systems engineered to provide an environment that mimics biofilms while enabling real-time microscopy. Specifically, the microfluidic systems developed and assessed as part of this thesis permit the visualization of individual bacteria cells within consortia growing within a narrow space provided by a microfluidic device. This research demonstrates the versatility of these microfluidic systems across potentially high-throughput microbiological experiments utilizing genetically engineered Escherichia coli. Before demonstrating the efficacy of these systems, the development of the field of synthetic biology over the past half century is reviewed, focusing on synthetic genetic circuits and their applications (Chapter 2). The first and main microfluidic device explored in this research was developed to mimic the nutrient-deficient conditions within biofilms by forcing media to enter the culture area through a narrow, torturous channel. The microfluidic channel was thin enough (0.97 μm) to prevent the motility of 1-μm-wide E. coli cells, enabling visualization of individual cells. The bacteria cultured in the device contained either a simple Plux-driven quorum sensing receiver (Chapters 3 and 5) or a LacI- and TetR-driven genetic toggle switch (Chapter 4). Under the culture conditions, the quorum sensing reporter signal was detected even without addition of the signaling molecule (Chapter 3). The genetic toggle switch was stable when the system began in the high-LacI expression state, but after 5 days of culture, >5% of high-TetR expression cells began to consistently express the high-LacI state (Chapter 4). This system was also employed to track lineages of cells using real-time microscopy, which successfully characterized the inheritance of aberrant, enlarged cell phenotypes under stress (Chapter 5). Another microfluidic device, a droplet bioreactor, was also developed to culture small numbers of cells in an aqueous bubble suspended in oil (Chapter 6). Quorum sensing receiver cellswere cultured in this device, demonstrating that it is well suited for testing the effects of compounds on biofilms within water-in-oil droplets. / Ph. D. / Bacteria are the most abundant organisms globally, yet relatively little is understood about the basic biology of biofilms, one of the most common natural states of bacteria. Biofilms are ubiquitous consortia of individual microbial cells that send and received chemical signals from one another to carry out group behaviors such as quorum sensing. The impacts of biofilms range from the contamination of food processing equipment to antibiotic resistant bacterial infections. The vast majority of microbiological research has been conducted on bacteria in their planktonic state as individual cells cultured in a liquid medium. This form of culture does not permit the types of research that can help address the impacts of biofilms on human health and economic activities, never mind examine the biological mechanism of random gene and morphological expression within bacterial biofilm. This thesis presents research utilizing two microfluidic devices that will enable further large-scale studies to unravel the mechanisms that create biofilms as well as permit high-throughput testing of chemical compounds to control the growth and development of biofilms. Moreover, these devices permit the use of real-time microscopy to track cells and their growth over time. The first microfluidic device utilized in this research mimics the nutrient-limiting conditions of biofilms. This biofilm-mimicking device was used to culture a common research bacteria, Escherichia coli, with one of two engineered genetic circuits (reviewed in Chapter 2): a quorum sensing receiver (Chapters 3 and 5) or genetic toggle switch (Chapter 4). Both of these genetic circuits demonstrated stochasticity in their gene expression states under the culture conditions in the biofilm-mimicking device. The second microfluidic device successfully permitted the culture of small numbers of isolated cells within a small bubble of bacterial media suspended in oil (Chapter 6). Additionally, this device enabled the addition of chemical compounds to influence the growth and metabolism of the trapped cells. Collectively, these microfluidic devices provide the ability to effectively study both the mechanisms underlying random gene expression within biofilms as well as explore the chemical factors that can be used to control and mitigate biofilm formation and growth.

Precise manipulation of heterogeneous droplets on an open droplet microfluidic platform could have numerous practical advantages in a broad range of applications, from proton exchange membrane (PEM) fuel cells and microreactors, to medical diagnostic platforms capable of assaying complex biological analytes. Toward the aim of developing electrically controllable micropost arrays for use in open droplet manipulation, custom-designed titanium dioxide (TiO2)- loaded poly(dimethylsiloxane) (PDMS) micropost arrays were developed in this work and indirectly mechanically actuated by applying an electric field. Initial experiments explored the bulk properties of TiO2-loaded PDMS films, with scanning electron microscopy (SEM) confirming a uniform TiO2 particle distribution in the PDMS, and tensile testing of bulk films showing an inverse relationship between TiO2 % (w/w) and Young’s Modulus with the Young’s Moduli quantified as 4.22 ± 0.51 MPa for unloaded PDMS, 2.27 ± 0.18 MPa for 10 % (w/w) TiO2, and 1.39 ± 0.20 MPa for 20 % (w/w) TiO2. Following bulk material evaluation, soft lithography methods were developed to fabricate TiO2- loaded PDMS micropost arrays. Mathematical predictions were applied to design microposts of varying shape, length, and gap spacing to yield super-hydrophobic surfaces actuatable by an electric field. Visual inspection and optical microscopy of the resulting arrays confirmed a non- collapsed micropost geometry. Overall, round microposts that were 100, 200, and 300 μm in length, 15 μm in diameter, and spaced 50 μm apart were produced largely free of defects, and used in contact angle measurements and micropost deflection experiments. Droplet contact angles measured on the arrays remained above 120° indicating the arrays successfully provided super- hydrophobic surfaces. Individual microposts deflected most notably above an electric field strength of 520 kV/m (12.5 kV nominal voltage). The ability to mechanically deflect customized microposts using an electric field demonstrated by this work is promising for translating this technology to precise droplet manipulation applications. Indirect actuation of droplets could enable the manipulation of liquids with varying electrical properties, which is a limitation of current micropumping technologies. Once optimized, electrically actuated micropost arrays could significantly contribute to the micro- handling of heterogeneous, highly ionic, and/or deionized fluids. / Thesis (Master, Chemical Engineering) -- Queen's University, 2013-03-03 17:25:49.785

Droplet microfluidics is an emerging technology for analysis of single cells and biomolecules at high throughput. The controlled encapsulation of particles along with the surrounding microenvironment in discrete droplets, which acts as miniaturized reaction vessels, allows millions of particles to be screened in parallel. By utilizing the unit operations developed to generate, manipulate and analyze droplets, this technology platform has been used to miniaturize a wide range of complex biological assays including, but not limited to, directed evolution, rare cell detection, single cell transcriptomics, rare mutation detection and drug screening. The aim of this thesis is to develop droplet microfluidics based methods for analysis of single cells and nucleic acids. In Paper I, a method for time-series analysis of mammalian cells, using automated fluorescence microscopy and image analysis technique is presented. The cell-containing droplets were trapped on-chip and imaged continuously to assess the viability of hundreds of isolated individual cells over time. This method can be used for studying the dynamic behavior of cells. In Paper II, the influence of droplet size on cell division and viability of mammalian cell factories during cultivation in droplets is presented. The ability to achieve continuous cell division in droplets will enable development of mammalian cell factory screening assays in droplets. In Paper III, a workflow for detecting the outcome of droplet PCR assay using fluorescently color-coded beads is presented. This workflow was used to detect the presence of DNA biomarkers associated with poultry pathogens in a sample. The use of color-coded detection beads will help to improve the scalability of the detection panel, to detect multiple targets in a sample. In Paper IV, a novel unit operation for label-free enrichment of particles in droplets using acoustophoresis is presented. This technique will be useful for developing droplet-based assays that require label-free enrichment of cells/particles and removal of droplet content. In general, droplet microfluidics has proven to be a versatile tool for biological analysis. In the years to come, droplet microfluidics could potentially be used to improve clinical diagnostics and bio-based production processes. / <p>QC 20160926</p>

The aim of this work is to establish novel strategies for the highly sensitive screening of cancer biomarkers in biological samples.To achieve this goal, we developed droplet-based microfluidic dPCR technique. Using a limiting dilution, individual DNA molecules are encapsulated within monodisperse droplets of a water-in-oil emulsion created with a microfluidic device. Fluorescent TaqMan® probes targeting the screened cancer biomarkers allow the detection of mutations. We focused on the mutations in the human KRAS gene for the development of our test. This method is also transposable in a multiplexed format for the parallel detection of multiple mutations in clinical samples.The developed technique allowed the precise quantification of a mutated KRAS gene in the presence of a 200,000-fold excess of un-mutated KRAS genes and enabled the determination of mutant allelic specific imbalance (MASI) in several cancer cell-lines. We validated our technique by screening for KRAS mutations in the blood plasma and tumor samples from patients with metastatic colorectal cancer.

Miniaturization of biological analysis is a trend in the field of biotechnology aiming to increase resolution and sensitivity in biological assays. Decreasing the reaction volumes to analyze fewer analytes in each reaction vessel enables the detection of rare analytes in a vast background of more common variants. Droplet microfluidics is a high throughput technology for the generation, manipulation and analysis of picoliter scale water droplets an in immiscible oil. The capacity for high throughput processing of discrete reaction vessels makes droplet microfluidics a valuable tool for miniaturization of biological analysis. In the first paper, detection methods compatible with droplet microfluidics was expanded to include SiNR FET sensors. An integrated droplet microfluidics SiNR FET sensor device capable of extracting droplet contents, transferring a train of droplets to the SiNR to measure pH was implemented and tested. In paper II, a workflow was developed for scalable and target flexible multiplex droplet PCR using fluorescently color-coded beads for target detection. The workflow was verified for concurrent detection of two microorganisms infecting poultry. The detection panel was increased to multiple targets in one assay by the use of target specific capture probes on color-coded detection beads.   In paper III, droplet microfluidics has been successfully applied to single cell processing, demonstrated in paper III, where reverse transcription was performed on 65000 individually encapsulated mammalian cells. cDNA yield was approximately equivalent for reactions performed in droplets and in microliter scale. This workflow was further developed in paper IV to perform reverse transcription PCR in microfluidic droplets for detection of exosomes based on 18S RNA content. The identification of single exosomes based on RNA content can be further developed to detect specific RNA biomarkers for disease diagnostics. Droplet microfluidics has great potential for increasing resolution in biological analysis and to become a standard tool in disease diagnostics and clinical research. / <p>QC 20171024</p>

Ce travail consiste à utiliser deux systèmes microfluidiques de gouttes pour incorporer d'une part des acides nucléiques dans des liposomes cationiques et d'autre part étudier la dynamique de transfection dans des cellules mammifères. La première micropuce permet d'insérer de l'ADN dans des liposomes cationiques afin d'obtenir de manière reproductible des lipoplexes appropriés à la transfection de cellules dendritiques (DC). Plusieurs paramètres expérimentaux sont tout d'abord étudiés, tels que les débits d'entrée, l’entretien des propriétés des liposomes après leur traitement dans des micro-gouttes, les caractéristiques des lipoplexes (taille, polydispersité et charge) en fonction du rapport molaire de charge (R+/-) et de la géométrie de la puce. Ensuite, les lipoplexes produits dans des conditions optimisées: une micropuce avec un grand canal en serpentin et une région de division des gouttes qui diminuent la polydispersité des lipoplexes, fonctionnant à un rapport de débit eau/huile 0,25 et R+/- 1,5; 3; 5; 7 et 10; sont utilisés pour transfecter des DCs in vitro. Tous les lipoplexes transfectent les DCs, tout en offrant une activation des DCs. La seconde étape consiste à utiliser une micropuce à l'échelle de la cellule unique afin de contrôler les conditions de transfection et d'optimiser le rendement de production de protéines recombinantes. Ainsi, des cellules ovariennes de hamster Chinois (CHO-S) sont transfectées dans la micropuce avec différents types de lipoplexes (R+/- 1,5; 3; 5) dont la dynamique de transfection est suivie par la production de protéines vertes fluorescentes (GFP) et par la viabilité cellulaire. Cette micropuce a permis d'évaluer l’hétérogénéité des cellules transfectées, révélant la présence d'une sous-population produisant des niveaux particulièrement élevés de GFP. Ces hautes productrices (HP) ont une taille cellulaire plus importante que celle de la population moyenne. La charge des lipoplexes montre un rôle important pour transfecter CHO-S, puisque l’unique lipoplex chargé positif R+/- 5 produit plus de HPs. La quantité d’ADN délivrée influe sur la production de protéine, puisque R+/- 1,5 avec plus d’ADN augmente la productivité spécifique de GFP des HPs. Cette thèse est réalisée dans le cadre d'un programme de co-tutelle entre l'Université de Campinas, au Brésil, et l'École Polytechnique, en France. Ce travail a principalement contribué aux domaines de microfluidique et de délivrance de gènes. / This work aims to use one droplet-based microfluidic systems to incorporate nucleic acids into cationic liposomes and another one to study the mammalian cell transfection process. For this, the first step uses a droplet-based microfluidic system to complex cationic liposomes with pDNA in order to obtain reproducible and suitable lipoplexes to dendritic cells (DCs) transfection. For this purpose, some experimental parameters are investigated, such as inlet flow rates, the maintenance of liposomes’ properties after microfluidic processing, lipoplex characteristics (size, polydispersity and zeta potential) as function of molar charge ratio (R+/-) and microchip design. Then, lipoplexes produced in selected conditions: a microchip with large serpentine channel and split region, which decreases lipoplex polydispersity, operating at ratio aqueous/oil flow rate 0.25 and R+/- 1.5, 3, 5, 7 and 10; are used to transfect DCs in vitro. All lipoplexes transfect DCs while providing cells activation. The second step uses a single-cell microfluidic platform to investigate and control over the transfection conditions, in view of optimizing the recombinant protein production by transfected cells. In this context, Chinese hamster ovary cells (CHO-S) are transfected in microchip with different types of lipoplexes (R+/- 1.5, 3, 5) and monitored by green fluorescent protein (GFP) production and cell viability. The single-cell platform enables to assess the heterogeneities of CHO-S population, revealing the presence of a subpopulation producing significantly high levels of GFP. These high producers (HP) show increased cell size in comparison to the average population. Moreover, the charge of lipoplexes shows an important role to transfect CHO-S, since the unique positive charged lipoplex R+/- 5 produces more HPs. Additionally, the amount of pDNA delivered affects the protein production, since R+/- 1.5 with more pDNA increase GFP specific productivity of HPs. This thesis is a co-supervised program between University of Campinas, Brazil and École Polytechnique, France. In general, this work contributes to microfluidics and gene delivery areas.

Today many cell biological techniques study large cell populations where an average estimate of individual cells’ behavior is observed. On the other hand, single cell analysis is required for studying functional heterogeneities between cells within populations. This thesis presents work that combines the use of microfluidic devices, optical microscopy and automated image analysis to design various cell biological assays with single cell resolution including cell proliferation, clonal expansion, cell migration, cell-cell interaction and cell viability tracking. In fact, automated high throughput single cell techniques enable new studies in cell biology which are not possible with conventional techniques. In order to automatically track dynamic behavior of single cells, we developed a microwell based device as well as a droplet microfluidic platform. These high throughput microfluidic assays allow automated time-lapse imaging of encapsulated single cells in micro droplets or confined cells inside microwells. Algorithms for automatic quantification of cells in individual microwells and micro droplets are developed and used for the analysis of cell viability and clonal expansion. The automatic counting protocols include several image analysis steps, e.g. segmentation, feature extraction and classification. The automatic quantification results were evaluated by comparing with manual counting and revealed a high success rate. In combination these automatic cell counting protocols and our microfluidic platforms can provide statistical information to better understand behavior of cells at the individual level under various conditions or treatments in vitro exemplified by the analysis of function and regulation of immune cells. Thus, together these tools can be used for developing new cellular imaging assays with resolution at the single cell level. To automatically characterize transient migration behavior of natural killer (NK) cells compartmentalized in microwells, we developed a method for single cell tracking. Time-lapse imaging showed that the NK cells often exhibited periods of high motility, interrupted with periods of slow migration or complete arrest. These transient migration arrest periods (TMAPs) often overlapped with periods of conjugations between NK cells and target cells. Such conjugation periods sometimes led to cell-mediated killing of target cells. Analysis of cytotoxic response of NK cells revealed that a small sub-class of NK cells called serial killers was able to kill several target cells. In order to determine a starting time point for cell-cell interaction, a novel technique based on ultrasound was developed to aggregate NK and target cells into the center of the microwells. Therefore, these assays can be used to automatically and rapidly assess functional and migration behavior of cells to detect differences between health and disease or the influence of drugs. The work presented in this thesis gives good examples of how microfluidic devices combined with automated imaging and image analysis can be helpful to address cell biological questions where single cell resolution is necessary. / <p>QC 20130927</p>